B

Baroness Chakrabarti (Lab)

Speaking in the House of Lords on 6 February 2025

Debate

AstraZeneca

Contribution

My Lords, I would call my noble friend the Minister a very dedicated public servant and not a bit complacent. Does he agree that a number of pharmaceutical companies, not least AstraZeneca, have benefited a great deal over the years from UK investment, including in universities and including through the purchasing power of the NHS, which is not inconsiderable? What do the Government plan to do to introduce an element of contingency into those relationships? Have the Government considered perhaps even their own state manufacturing capacity?

More from Baroness Chakrabarti (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites